Prot #AV-951-09-901: A Rollover Protocol to Allow Continued Access to Tivozanib Hydrochloride (AV-951) for Subjects Enrolled in Other Tivozanib Hydrochloride Protocols

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/16/131/16/16

Funding

  • AVEO Pharmaceuticals, Inc. (Prot #AV-951-09-901)